Patent ID: 11873492
Assignee: ZHEJIANG CHINESE MEDICAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A medication for inhibiting metastasis and invasion of breast cancer, comprising shRNAs for inhibiting expression of human LINC01614, wherein the shRNAs for inhibiting expression of human LINC01614 comprises a shRNA-1 and/or a shRNA-2, a sense strand nucleotide sequence of the shRNA-1 is shown as SEQ ID No. 3, an antisense strand nucleotide sequence of the shRNA-1 is shown as SEQ ID No. 4, a sense strand nucleotide sequence of the shRNA-2 is shown as SEQ ID No. 5, and an antisense strand nucleotide sequence of the shRNA-2 is shown as SEQ ID No. 6.